Division of Hepatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Shiwa, Iwate, Japan.
Department of Gastroenterology, Sato Clinic, Hanamaki, Iwate, Japan.
Am J Case Rep. 2021 Aug 18;22:e931369. doi: 10.12659/AJCR.931369.
BACKGROUND Reactivation of latent tuberculosis infection (LTBI) is a recognized complication of immunosuppressive treatment. However, immunosuppressed patients are also at risk of hematogenous disseminated spread from a primary infection with Mycobacterium tuberculosis. This report presents the case of a 55-year-old Japanese man with a 12-year history of multiple sclerosis who was hospitalized with worsening neurological symptoms and was diagnosed with disseminated tuberculosis identified by abnormalities on liver function test results. CASE REPORT A 55-year-old Japanese man was admitted to our hospital for the treatment of multiple sclerosis with worsening symptoms. He showed mild liver dysfunction at the time of admission. A laparoscopy and biopsy were performed to identify the cause of the liver dysfunction, which was the only positive finding. The liver surface was studded with yellowish-white nodular lesions. Histological examination of a liver biopsy specimen revealed a granuloma without caseous necrosis. The patient was suspected of having tuberculosis. Although the results of an interferon-γ-releasing assay were indeterminate, asymptomatic disseminated tuberculosis was diagnosed from the serum adenosine deaminase levels, a caseating granuloma in the cervical lymph node, detection of acid-fast bacilli DNA in the cervical lymph nodes on polymerase chain reaction, and tuberculin skin test findings. Anti-tuberculosis treatment led to improvement in the liver function test findings. CONCLUSIONS This case has highlighted that tuberculosis may have an atypical presentation in the immunosuppressed patient. In addition to the reactivation of LTBI, hematogenous spread of primary tuberculosis may result in disseminated disease involving multiple organs and requiring emergency treatment.
潜伏性结核感染(LTBI)的再激活是免疫抑制治疗的一种公认并发症。然而,免疫抑制患者也有发生血源播散性结核分枝杆菌原发性感染的风险。本报告介绍了一例 55 岁日本男性,患有多发性硬化症 12 年,因神经症状恶化住院,肝功能检查结果异常诊断为播散性结核。
一名 55 岁日本男性因多发性硬化症症状恶化入住我院。入院时他出现轻度肝功能异常。为明确肝功能异常的病因进行了腹腔镜检查和活检,这是唯一的阳性发现。肝表面散布着黄白色小结节状病变。肝活检标本的组织学检查显示无干酪样坏死的肉芽肿。患者被怀疑患有结核病。尽管干扰素-γ释放试验结果不确定,但从血清腺苷脱氨酶水平、颈部淋巴结干酪样肉芽肿、颈部淋巴结聚合酶链反应检测到抗酸杆菌 DNA 以及结核菌素皮肤试验结果,诊断为无症状播散性结核。抗结核治疗导致肝功能检查结果改善。
本病例强调了在免疫抑制患者中,结核病可能表现出非典型特征。除 LTBI 的再激活外,原发性肺结核的血源性播散可能导致涉及多个器官的播散性疾病,需要紧急治疗。